Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Study to access the safety, levels of drug in the blood and tumor effects of sorafenib dosed
daily combined with Cyclophosphamide and Doxorubicin in cancer patients